Embryonic stem (ES) cells provide a unique tool for producing specifically designed mutations in mice. Here, we describe an alternative approach toward the generation of mice which are derived completely from ES cells (ES mice), as judged by glucose phosphate isomerase (GPI) analysis, without prior passage through the germline. By injecting wild-type and mutant ES cells into tetraploid blastocysts, viable and fertile ES mice were generated, suggesting that totipotency of ES cells was not affected by long-term culture and experimental manipulation in vitro. When ES cell clones harboring a lacZ reporter gene introduced by either targeted insertion or a gene-trap approach were used, the expression pattern of the lacZ gene in ES fetuses was identical to that of fetuses that were derived from breeding of chimeric mice. Thus, this technique can be considered as a useful and rapid approach to produce fetuses and mice directly from ES cells carrying predetermined genetic changes and offers many applications for studies in molecular genetics and developmental biology.
Introduction
Mouse embryonic stem (ES) cells are derived from the inner cell mass (ICM) of blastocysts and are the most totipotent cells that can develop to all cell lineages, including germ cells, when introduced into the embryonic environment by either diploid blastocyst injection or morula aggregation (Bradley, 1987; Robertson, 1987; Beddington and Robertson, 1989; Nagy et al., 1990) . ES cells can be cultured under defined conditions and can be genetically manipulated in vitro, thereby providing a powerful tool for modifying the mouse genome, for example, by introducing targeted mutations and other genetic alterations into mice (for review, see Capecchi, 1989; Wagner et al., 1991; Ramirez-Solis et al., 1993; Skarnes, 1993; Bronson and Smithies, 1994) .
Various experimental techniques have been developed over the years to maintain the full developmental potential of ES cells in vitro (Smith et al., 1988; Williams et al., 1988) and to restrict the developmental potential of host cells in the generation of chimeras in order to increase the frequency of germline chimera formation (Kaufman and Webb, 1990; Nagy et al., 1990) . One of the most important advances is the application of tetraploid embryos as host cells since tetraploid cells have only a limited potential in postimplantation development (Kubiak and Tarkowski, 1985; Kaufman and Webb, 1990; Nagy et al., 1990) . When tetraploid embryos are aggregated with diploid embryos the differentiation of tetraploid cells is mostly restricted to primitive endoderm and trophectoderm which will form extraembryonic tissues, whereas the diploid cells can form the embryo proper (James and West, 1994; James et al., 1995) . In an earlier study several ES cell lines were used to produce completely ES cellderived fetuses by aggregation with tetraploid morulae; however, the obtained ES fetuses died at birth (Nagy et al., 1990) . Further studies demonstrated successful generation of viable and fertile ES mice which were derived exclusively from ES cells when early passage wild-type R1 and TT2 (Ueda et al., 1995) cells were used for aggregation with tetraploid morulae.
However, the goal to obtain viable ES mice using later passage ES cells was not reached and the production of ES mice using genetically modified ES cells did not seem to be possible. In the present study we describe a successful route towards the production of mutant ES mice by injection of ES cells into tetraploid blastocysts. This technique allows viable and fertile mutant ES mice to be generated with ES cells following genetic manipulation in vitro.
Results

Chimeric mice derived from diploid embryos and wild-type ES cells
To test the developmental potential, four different wild-type ES cell lines at early passages (D3, R1, J1 and GS1) were first used to generate chimeric mice by either diploid morula aggregation or diploid blastocyst injection. As summarized in Table 1 , all four ES cell lines can produce high chimerism and germline chimeras at a high frequency when introduced into diploid mouse embryos. Interestingly, a high proportion of female chimeras was obtained with R1 and J1 cells, some of which transmitted the 129 coat color to their offspring when crossed with C57BL/6 mice (Table 1) . In summary, all four ES cell lines tested can produce germline chimeras at a high frequency when introduced into diploid mouse embryos.
Viable ES mice generated by tetraploid embryo aggregation and blastocyst injection
In order to produce tetraploid embryos, the blastomeres of diploid embryos at the two-cell stage were fused after a short electric pulse. Examination of the embryos after a 15-min culture period in M16 medium revealed that about 90% of them fused and survived after the electric shock (Fig. 1A-C) . These embryos were further cultured and developed at a high frequency to morulae and to blastocysts (68-98%). The morulae were used for aggregation with ES cells and the blastocysts were used for ES cell injections (Fig. 1D-F) . In order to produce ES mice, five wild-type ES cell lines, D3, R1, J1, GS1 and E14.1 were tested. Although 26 live newborns derived from aggregation with D3 cells were obtained following Cesarean section, none of them survived (Table 2) . Similarly, J1 cells were also not able to produce viable ES mice (Table 2) . However, R1 cells aggregated with tetraploid morulae gave rise to ES mice at a similar frequency as previously reported (Table 2 ) (see also .
Since the blastocyst injection method results in a high efficiency of chimera formation compared to the aggregation method (see also Wood et al., 1993) , we next tested whether ES mice can be produced by injecting wild-type ES cells into tetraploid blastocysts. Using D3 cells at passage 9, a relatively high frequency (28%) of fully developed fetuses at E18.5 could be recovered by Cesarean section (Table 2) ; however, they failed to sustain respiration and died shortly thereafter. Interestingly, these newborns also displayed increased body weight and polydactyly (data not shown). In contrast, nine viable pups from 36 tetraploid blastocysts injected with R1 cells (passage 14) were recovered by Cesarean section at Wild-type ES cell lines were either aggregated with or injected into diploid embryos derived from C57BL/6 mice. All four ES cell lines were originally isolated from 129 mice. Some of the chimeras were tested for germline transmission by breeding with C57BL/6 mice. Agouti coat color of the resulting offspring indicated germline transmission. M, males; F, females.
E18.5 (Table 2 ). Five of them were able to sustain respiration and were fostered by a foster mother. Unfortunately, two pups were lost after 7 days and one was found dead at 5 weeks of age. Two ES mice survived to adulthood and showed complete germline transmission (Table 2) . When GS1 ES cells were injected into tetraploid blastocysts, 17 embryos developed to term from 54 blastocysts injected (Table 2) . After Cesarean section, six newborns were recovered which sustained their respiration. Five died within 48 h and only one ES mouse survived to adulthood Wild-type and manipulated ES cells were either aggregated with or injected into tetraploid embryos which were derived from B6CBAF2 (C57BL/ 6 × CBA) embryos. R-169.2.3 and R-169.2.5 clones were generated after electroporation of SV40-neo-MTc-fosLTR and selection for neomycin resistance. R-fra3 is an ES clone in which one allele of the fra-1 gene was disrupted by homologous recombination. GS1-175.3 is a clone transfected with CMV-fra-1 vector. E14.1-120/75 is a clone which contained a 'floxed' Pax5 locus. Germline chimeras were identified by the production of offspring displaying the 129 coat color and the presence of the GPI-1A marker when bred to C57BL/6 mice. M, males; F, females. a Live fetuses were scored by the appearance of functional cardio-vascular system immediately after Cesarean section. b Newborns which sustained respiration; the frequency was calculated based on the number of embryos transferred.
and transmitted ES cell derivatives to offspring (Table 2) . Finally, the ability of E14.1 ES cells to produce viable ES mice was also tested and only a low frequency of ES newborns was obtained (Table 2) .
Generation of ES mice with genetically modified ES cell clones
Since injection of R1, GS1 and E14.1 ES cells into tetraploid blastocysts resulted in viable ES mice, we next asked whether using this procedure we can produce mutant ES mice from genetically manipulated ES cells. First, R1 ES cells were electroporated with a c-fos expression vector and two G418-resistant clones, R-169.2.3 and R-169.2.5, were used for tetraploid blastocyst injection. These R1 clones were cultured for more than 24 passages before they were used for production of ES mice. A total of 103 embryos were injected with clone R-169.2.5 and 12 newborns were obtained by Cesarean section. Three of them sustained respiration, but died after 48 h (Table 2) . Clone R-169.2.3 gave a higher frequency of surviving newborns, as 23 pups were alive after Cesarean and 12 were fostered (Table 2) . Unfortunately, because of bad husbandry seven newborns died in the first 3 days and two were subsequently lost during the weaning period. Three of them survived to adulthood and two transgenic lines were established after the transgene was transmitted to offspring, as confirmed by Southern blot analysis (data not shown). In a second experiment we used one R1 ES clone, R-fra3 (fra-1 +/−) (passage 24), in which one allele of the Fos-related antigen 1 (Fra-1) gene was disrupted by homologous recombination. Forty-eight tetraploid blastocysts were injected with R-fra3 cells and eight live pups were obtained by Cesarean section. Four out of five fostered newborns survived to adulthood, of which three were shown to transmit the targeted allele (fra-1 +/−) to their offspring ( Table 2 ). The female chimera was sterile despite the fact that female chimeras generated by wildtype R1 cells with diploid embryos could give rise to germline offspring (see Table 1 ). When the GS1 clone (GS1-175.3) harboring a fra-1 expression vector (CMVfra-1) was injected into tetraploid blastocysts, one ES mouse survived out of eight live ES fetuses but was lost within 48 h due to bad husbandry (Table 2) . To produce mutant ES mice, we also used one E14.1-derived clone in which the Pax5 gene was flanked by loxP sites and which went through two rounds of transfection and selection (M. Horcher et al., unpublished data) . When 24 tetraploid blastocysts were injected, two live ES fetuses were delivered by Cesarean and one could be recovered and was fostered (Table 2) . Unfortunately, this one also died after 5 days during the fostering period.
GPI analysis in tissues of ES fetuses and ES mice
To confirm that fetuses and adult mice generated using wild-type D3, R1, J1 and GS1 cells by aggregation with or injection into tetraploid embryos were indeed exclusively of ES cell origin, glucose phosphate isomerase (GPI) analysis was performed. In the aggregation experiments, all 11 fetuses from D3 cells, one from R1 cells and one from J1 cells showed complete GPI-1A (ES cell) contribution in all tissues examined (Table 3) . However, a minor contribution of tetraploid cells (less than 2%) could not be detected using the GPI analysis because of the limits of sensitivity of the assay. One fetus generated from R1 cells contained a minor contribution (about 10%) of host cells in the heart, although other tissues were exclusively ES cellderived ( Fig. 2A ; Table 3 ). Similarly, most ES fetuses and all R1-and GS1-derived adult ES mice generated by tetraploid blastocyst injection were derived exclusively from ES cells, except for two of the D3 cell-derived fetuses at E18.5 which contained 10-50% of host cells in liver, lung and heart (Table 3) . Notably, four R1-derived fetuses at E13.5 exhibited already at this early stage only the ES cellspecific GPI-1A marker (Table 3 ). In addition, offspring of R1-derived ES mice were further examined by GPI analysis and were shown to be of ES cell origin (Fig. 2B) .
ES fetuses and adult mice generated by injection of genetically altered R1 cells were also examined by GPI analysis. Tissues from two newborn pups (E18.5) derived from the R-169.2.5 ES clone exhibited exclusive ES cell origin (data not shown). GPI analysis of 3-day-old newborns (P3) and adults which were generated by R1 cells either overexpressing a c-fos transgene (R-169.2.3) or with an inactivated allele of fra-1 (R-fra3) showed complete ES contribution in all tissues analyzed (Table 3) . Furthermore, GPI and Southern blot analyses were performed on offspring of these ES mice confirming that they all contained Fig. 2 . GPI analysis of R1-derived ES-newborn (A) and offspring of ES mice (B). (A) Protein was extracted from various tissues of a newborn ES mouse which was generated by the aggregation method. All tissues, except for placenta and heart, contained only GPI-1A marker which indicates complete contribution of ES cells. (B) Analysis of the blood of four pups from an adult ES mouse showed exclusive GPI-1A isoenzyme, which confirmed their ES cell origin.
only GPI-1A marker; some of them also inherited either the transgene (c-fos) or the targeted allele (fra-1) (data not shown).
Comparison of gene expression patterns in ES cellderived and germline embryos
To further evaluate the usefulness of the ES mouse approach in studying gene expression and mutant phenotypes, we compared the temporal and spatial expression pattern of specific genes in ES cell-derived and 'germlinederived' fetuses. Two genetically manipulated ES cell clones containing the lacZ reporter gene were chosen for this analysis, one giving rise to a restricted lacZ expression The chimerism of ES cell-derived fetuses and mice was analyzed by GPI markers. The contribution of ES cell derivatives in fetuses and mice was estimated by comparing the intensity of GPI-1A-(ES cell marker) versus GPI-1B-(from host cells) specific bands on the electrophoresis plate (see Section 4). E13.5, E16.5 and E18.5 are day 13.5 p.c., day 16.5 p.c. and day 18.5 p.c., respectively; P3 is 3 days postnatal; -, not determined; Liv., liver; Hea., heart; Int., intestine; Bra., brain; Spl, spleen; Sto., stomach; Kid., kidney; Mus., muscle; Tes, testis; Blo., blood; Lim., limbs. pattern (Pax5 +/− ES clone D3-15, see also Urbánek et al., 1994) and the second one displaying a widespread bgalactosidase staining (see below). At E9.5, embryos derived from tetraploid blastocysts which were injected by the D3-15 clone showed specific expression of the lacZ gene at the midbrain-hindbrain boundary (Fig. 3A) , a staining pattern identical to that in embryos obtained from heterozygote matings (Fig. 3B ) (see also Urbánek et al., 1994) . The second ES cell clone was an R1 clone, R-bgeo3, that was derived from a gene-trap experiment (P. Urbánek et al., unpublished) . R-bgeo3 cells were injected into diploid and tetraploid blastocysts. The injected diploid embryos gave rise to fertile chimeras and some of them transmitted the lacZ transgene to their offspring (data not shown). After 4-5 months a transgenic mouse line was established and the expression pattern of the lacZ gene was analyzed. By tetraploid blastocyst injection, embryos derived from R-bgeo3 cells were dissected at day 8.5 of gestation and stained for b-galactosidase activity. Intense staining was detected throughout the embryo proper, amnion membrane and allantois, but not in the yolk sac (Fig. 3C ). This pattern was identical to that in embryos generated by heterozygote intercrosses (Fig. 3D) . These results indicate that the expression pattern in ES mice faithfully reflected the true expression profile in heterozygous animals obtained by germline transmission.
Discussion
In the present study we demonstrate for the first time the successful production of viable and fertile mutant ES mice directly from genetically manipulated ES cells. This approach includes the generation of tetraploid blastocysts and microinjection of ES cells into these embryos. ES mice can be generated reproducibly from ES cell clones selected for either overexpression or inactivation of specific genes. This procedure may improve the conventional transgenic methodology by providing a flexible and rapid approach to generate mutant mouse fetuses and transgenic strains directly from ES cells with predetermined genetic changes.
All three ES cell lines, D3, R1 and GS1, formed germline chimeras equally well after injecting into diploid blastocysts; however, only R1 and GS1 cells gave rise to live ES mice following injection into tetraploid blastocysts. D3 cells, even at an early passage (passage 9), failed to produce viable ES mice using the tetraploid blastocyst injection technique, which is consistent with previous observations from aggregation experiments (Nagy et al., 1990 ; see also Table 2 ). The failure of D3 cells to generate viable ES mice could not be due to the loss of developmental potential since D3 cells have been used extensively in gene targeting experiments and were efficient in producing high chimerism and germline chimeras when injected into diploid blastocysts (Wang et al., 1992 Urbánek et al., 1994 ; see also Table 1 ). However, it is possible that the potential of D3 cells to differentiate into some cell types which are critical for the fetus in adapting to postnatal life may be impaired due to unknown genetic or epigenetic changes. This notion is supported by the observation that D3 cells can support fetuses to develop to term; however, the newborns fail to sustain respiration, display increased body size, polydactyly, and die at birth. These features are reminiscent of phenotypical characteristics of mice lacking the imprinted Igf2/Mpr gene (Lau et al., 1994; Wang et al., 1994) , suggesting that imprinted genes or genes regulating fetal growth might be responsible for the observed effect. Whereas the impaired function of ES cells could be complemented by host cells of diploid embryos, the developmental totipotency of D3 cells to form all functional cell types in a completely ES cellderived environment seems to be restricted. Thus, the introduction of ES cells into tetraploid embryos may also provide a fast and rigorous test for assessing the quality of ES cells under study. At present, it is not clear whether the genetic background of mouse strains from which different ES cells were derived influences the viability of ES mice. All ES cell lines used in this study were from mouse strain 129: R1 cells were derived from a blastocyst of an intercross between 129/Sv and 129/Sv-CP substrains and GS1 cells were from 129/Sv/Ev (M. Aguet, personal communication), whereas D3 cells (Doetchmann et al., 1985) and J1 cells (Li et al., 1992) were derived from 129/Sv and 129/terSv, respectively. Moreover, E14.1 cells derived originally from 129/Ola (Hooper et al., 1987; Kühn et al., 1991) can give rise to viable ES mice but at a low frequency (Table 2 ). In addition, TT2 cells which also gave rise to ES mice were derived from a hybrid strain F1 (C57BL/6 × CBA) (Yagi et al., 1993) . Based on our results and previous reports Ueda et al., 1995) , we cannot rule out the possibility that ES cell lines originating from different mouse strains or substrains exhibit different capacities to form viable ES mice. It is worth mentioning that R1 and TT2 ES cells which produce a relatively high frequency of viable ES mice were derived from hybrid embryos of two substrains and strains, respectively, whereas GS1 and E14.1 which produce ES mice inefficiently were from inbred substrains.
The efficiency of generating newborn ES mice by injection of wild-type R1 cells (14%) was higher compared to the aggregation method, which was 6% in the present study and 7% in the previously published report . This is consistent with the observation when the aggregation and injection methods were compared using diploid embryos (Wood et al., 1993) . Using the tetraploid blastocyst injection method, several selected R1 cell clones (e.g. R-169.2.3 and R-fra3) that have been experimentally manipulated and cultured in vitro for more than 24 passages still produce efficiently viable ES mice. In addition, GS1 and E14.1 cells that have been manipulated following DNA transfection and selection for over-expression of the fra-1 oncogene (GS1) or for disrupting Pax5 by homologous recombination (E14.1) were still able to produce viable ES mice following injection into tetraploid blastocysts, albeit at a low frequency (Table 2) . These data are striking in view of results from previous aggregation experiments where wild-type R1 cells lost their totipotency in producing viable ES mice after passage 14. It is worth mentioning that one subline (R1-S3) derived from the parental R1 cell line could produce viable ES mice . However, there is no report on the successful production of ES mice by aggregation using genetically modified R1 cells. The reasons why injection of ES cells into tetraploid blastocysts can increase the efficiency of ES mouse production are not clear. Since ES cells are originally isolated from ICM of blastocysts and closely resemble these ICM cells (Beddington and Robertson, 1989) , it is conceivable that the co-localization of ES cells with ICM and the developmental compatibility between ES cells and the ICM cells could account for this effect. This notion is further supported by the observation that when ES cells were introduced into diploid morulae under the zona pellucida the efficiency of generating chimeric mice was lower compared to the conventional blastocyst injection method (our unpublished data).
Using tetraploid blastocyst injection, a number of ES cell lines which have been genetically manipulated in vitro were able to produce ES mice. However, this technique cannot, at present, replace conventional diploid blastocyst injection for routine generation of mutant mouse strains because of observed inefficient postnatal development of ES mice, e.g. Cesarean delivery and fostering. Nevertheless, the tetraploid blastocyst injection procedure is the only way to produce mutant mice directly from genetically altered ES cells. Despite the present inefficiency, the generation of viable mutant ES mice directly from genetically manipulated ES cells has many advantages. Since the fetal tissues are completely derived from ES cells which can be genetically modified, this technique offers a direct way to prepare pure fetal material of ES cell origin for cellular and molecular biology as well as genetic studies (Forrester et al., 1991; Chambers et al., 1994) . ES fetuses faithfully reproduce the expression pattern of specific genes, e.g. the Pax5 gene and a 'trapped' gene, when compared to that in fetuses derived from intercrosses of heterozygous mutant mice originating from the same ES cells. It is advantageous to use ES fetuses for expression studies, since they offer rapid access to embryonic material within a few days compared to the conventional breeding procedure which usually takes several months. Moreover, the reliable and reproducible expression pattern in ES fetuses will minimize possible complications in conventional chimeric tissues which, per definition, are composed of both wild-type host and mutant ES cells. Therefore, this technique will be useful for studies on gene function as well as for the characterization of gene expression, e.g. in gene-trap studies (for review see Skarnes, 1993) . Using the tetraploid blastocyst injection technique we demonstrated that mutant mouse strains, for example, c-fos transgenic and fra-1 knock-out mice can be generated directly from the mutant ES cells in an efficient manner. Therefore, the ES mice approach provides a possibility to produce transgenic mouse lines from ES cells which were pre-selected for the integration and for the expression of the transgenes. This may significantly improve the efficiency of generating mice overexpressing a particular gene, when compared to the conventional DNA injection technique. We have applied this approach to several gain-of-function and loss-of-function studies. For example, when fra-1 −/− ES cells were injected into 42 tetraploid blastocysts, ten ES fetuses developed beyond the stage when homozygous fetuses derived from heterozygous intercrosses die (M. Schreiber et al., unpublished data) . Similarly, when 23 tetraploid blastocysts were injected with junB −/− ES cells, 12 ES fetuses developed to midgestation (E12-14) whereas the junB −/− embryos obtained from heterozygous intercross die 3-4 days earlier (M. Schorpp et al., unpublished data) . More importantly, if inactivation or overexpression of certain genes result in lethality or impaired gametogenesis in heterozygous mutants or even in chimeras, this approach may allow the generation of mutant tissues for studying specific effects of a given gene (for example, see Carmeliet et al., 1996) . Finally, the practical benefit of this technique should be emphasized as it may save time and money for generating mutant mouse strains from cultured ES cells and allows a rapid access to mutant fetuses and mice, a potential advantage for many investigators in the field of mouse genetics.
Experimental procedures
Mice
Mouse stocks used for diploid embryo donors were C57BL/6 and for tetraploid embryo donors, B6CBAF1 (C57BL/6 × CBA). Both of these donor strains are homozygous for the Gpi-1 b allele at the Gpi-1 locus, which encodes GPI. (Friedrich and Soriano, 1991) , containing a promoterless lacZ-neo fusion gene.
ES cells and gene transfer
Collection of two-cell embryos and electrofusion
Two-cell embryos were isolated from day 1.5 post-coitum (p.c.) pregnant B6CBAF1 females (Fig. 1A) . Tetraploidy of embryos was achieved by electrofusion (James et al., 1992 ) using a modification of the procedure described previously . Briefly, two-cell embryos were equilibrated in 0.3 M mannitol solution for 30 s before they were placed individually between two platinum electrodes in 0.3 M mannitol (Fig. 1B) . The blastomeres were fused following a short electric pulse at 95 V for 30 ms in an effective field (2 V) using a pulse generator CF-100 (Biochemical Laboratory Service, Budapest, Hungary) (Fig. 1C) . After the electric pulse, the fused embryos were scored and further cultivated in a microdrop of M16 medium under paraffin oil at 37°C in a 95% air/5% CO 2 incubator.
Morula aggregation and blastocyst injection
For aggregation, morulae were either isolated from oviducts of day 2.5 p.c. pregnant females or derived from one-cell tetraploid embryos by culturing them for 24-40 h after electrofusion. ES cell preparation and aggregation were performed as described previously (Nagy et al., 1990) . Diploid blastocysts were isolated from uteri of day 3.5 p.c. pregnant C57BL/6 females. For obtaining tetraploid blastocysts, the electrofused one-cell embryos were cultured for 48-60 h after fusion (Fig. 1D) . ES cells were then injected into blastocysts as described previously ; see also Fig. 1E,F) . Whereas injected diploid embryos developed to term and were delivered naturally, pregnant recipients with tetraploid embryos were subjected to Cesarean section on day 18.5 of gestation (see also Nagy et al., 1990) . Viable fetuses, as judged by a beating heart and sustained breathing, were fostered by a female who had delivered a litter on the same day or 1 day before. Some of the live pups were also subjected to analysis of glucose phosphate isomerase (GPI) marker. Surviving ES mice were further bred to wild-type C57BL/6 mice to test fertility and germline transmission.
GPI isoenzyme analysis
Various tissues of ES cell-derived fetuses or adults were dissected and minced in distilled water. Samples were lysed by three cycles of freezing-thawing and were subjected to GPI analysis as described previously (Bradley, 1987; Wang et al., 1991) . The proportion of ES-and hostderived cells in the chimeric tissues was estimated from the ratio of the GPI-1A versus GPI-1B isozyme activity after visualization in a coupled optical assay.
b-Galactosidase histochemistry
A modified method of Sanes et al. (1986) was used to detect b-galactosidase activity in whole mount embryos. Embryos and their extraembryonic membranes were dissected at different developmental stages and fixed for 5-10 min on ice in a fixing solution (100 mM sodium phosphate, pH 7.4, 5 mM EGTA, 2 mM MgCl 2 , 0.2% glutaraldehyde). Embryos were washed three times for 10 min at room temperature in a washing solution (100 mM sodium phosphate, pH 7.4, 2 mM MgCl 2 , 0.01% sodium deoxycholate, 0.02% Nonidet P-40), and then stained for 4 h to overnight at 37°C in a histochemical reaction mixture (100 mM sodium phosphate, pH 7.4, 2 mM MgCl 2 , 0.01% sodium deoxycholate, 0.02% Nonidet P-40, 5 mM potassium ferricyanide, 5 mM potassium ferrocyanide and 1 mg/ml X-Gal), which was filtered through a 0.22 mm Millipore filter before use. Stained embryos were rinsed with PBS, post-fixed for several hours to overnight at 4°C in 4% formaldehyde in PBS, and stored at 4°C in PBS.
